Home - Clinical Trials Arena
WEBBioinformatics companies and clinical trial technology companies for the clinical trials industry. Buyer's Guides.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Decentralised clinical trials: IQVIA on the future of remote trials
WEBFeb 25, 2021 · Decentralised clinical trials are a lifeline for research groups amid the chaos of Covid-19. How are trials changing with remote tech?
Kazia begins Phase II trial of paxalisib for glioblastoma in US
WEBFeb 28, 2022 · Kazia Therapeutics has commenced a Phase II clinical trial of its paxalisib, along with metformin and a ketogenic diet to treat glioblastoma.
Treximet – Next-Generation Treatment for Migraine - Clinical Trials …
WEBAug 9, 2006 · The product of a joint development programme between US drug development company Pozen and GSK, Treximet is a novel combination therapy consisting of sumatriptan and naproxen sodium in a single tablet for the treatment of acute migraine. Following completion of pivotal Phase III trials on the new combination therapy, the companies filed for ...
Linear Clinical to conduct study of Covid-19 vaccine candidate
WEBApr 28, 2020 · Linear Clinical Research is set to perform a clinical trial of a Covid-19 vaccine candidate developed by China-based Clover Biopharmaceuticals.
Argenica Therapeutics greenlit to launch Phase II trials into stroke ...
WEBOct 4, 2023 · The Australian company developing ARG-007 to treat death of brain cells following a stroke has received the nod to begin Phase II trials.
Alzheimer's trials: How does donanemab compare to lecanemab?
WEBJan 13, 2023 · Eli Lilly hopes donanemab will soon nab the second Alzheimer’s drug approval of 2023. Here’s a look at how donanemab stacks up to lecanemab.
Biosyngen receives FDA approval to start Phase I trial for TCR …
WEBSep 11, 2023 · The US FDA has awarded Biosyngen’s IND for the T-cell receptor therapy, BRL03, to start Phase I/II trials in lung and other solid cancers.
Merck and Moderna start cancer vaccine and Keytruda combo trial …
WEBDec 12, 2023 · Merck and Moderna are also conducting a Phase III trial evaluating the combination therapy in patients with resected high-risk melanoma.
Skip to content